CUTANEOUS DISORDERS AND VIRAL GENE-EXPRESSION IN HIV-1 TRANSGENIC MICE

被引:45
作者
KOPP, JB
ROONEY, JF
WOHLENBERG, C
DORFMAN, N
MARINOS, NJ
BRYANT, JL
KATZ, SI
NOTKINS, AL
KLOTMAN, PE
机构
[1] NIDR,ORAL MED LAB,BETHESDA,MD 20892
[2] NIDR,ANIM CARE UNIT,BETHESDA,MD 20892
[3] NCI,DERMATOL BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1089/aid.1993.9.267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients infected with HIV-1 experience several hyperproliferative skin disorders, including seborrheic dermatitis, ichthyosis, and psoriasis. Transgenic mice carrying a subgenomic HIV-1 proviral construct lacking the gag and pol genes were found to develop proliferative epidermal lesions, manifested as diffuse epidermal hyperplasia in homozygous transgenic mice and benign papillomas in heterozygous transgenic mice. Nonpapillomatous skin from both homozygotes and heterozygotes expressed viral RNA, and the viral envelope protein gp120 was localized to the suprabasal keratinocyte. Papillomas contained increased amounts of both viral mRNA and envelope glycoprotein. Exposure of transgenic mice to doses of ultraviolet B (UV-B) irradiation that induced cutaneous injury increased viral gene expression and resulted in the development of papillomas within 14-21 days. Cutaneous injury induced by phenol and liquid nitrogen had similar effects. These data support a role for HIV-1 gene products in the pathogenesis of proliferative epidermal disorders associated with HIV-1 infection. Further, they suggest that the process of wound repair increases HIV-1 gene expression in this transgenic mouse model.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 32 条
[1]   NEF PROTEIN OF HIV-1 IS A TRANSCRIPTIONAL REPRESSOR OF HIV-1 LTR [J].
AHMAD, N ;
VENKATESAN, S .
SCIENCE, 1988, 241 (4872) :1481-1485
[2]   SKIN HYPERKERATOSIS AND PAPILLOMA FORMATION IN TRANSGENIC MICE EXPRESSING A RAS ONCOGENE FROM A SUPRABASAL KERATIN PROMOTER [J].
BAILLEUL, B ;
SURANI, MA ;
WHITE, S ;
BARTON, SC ;
BROWN, K ;
BLESSING, M ;
JORCANO, J ;
BALMAIN, A .
CELL, 1990, 62 (04) :697-708
[3]   INVIVO ACTIVATION BY ULTRAVIOLET RAYS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT [J].
CAVARD, C ;
ZIDER, A ;
VERNET, M ;
BENNOUN, M ;
SARAGOSTI, S ;
GRIMBER, G ;
BRIAND, P .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) :1369-1374
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]   PREVALENCE AND CLINICAL SPECTRUM OF SKIN-DISEASE IN PATIENTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
COLDIRON, BM ;
BERGSTRESSER, PR .
ARCHIVES OF DERMATOLOGY, 1989, 125 (03) :357-361
[6]   HIV-ASSOCIATED NEPHROPATHY IN TRANSGENIC MICE EXPRESSING HIV-1 GENES [J].
DICKIE, P ;
FELSER, J ;
ECKHAUS, M ;
BRYANT, J ;
SILVER, J ;
MARINOS, N ;
NOTKINS, AL .
VIROLOGY, 1991, 185 (01) :109-119
[7]   ACQUIRED-IMMUNODEFICIENCY-SYNDROME - ASSOCIATED PSORIASIS AND REITERS-SYNDROME [J].
DUVIC, M ;
JOHNSON, TM ;
RAPINI, RP ;
FREESE, T ;
BREWTON, G ;
RIOS, A .
ARCHIVES OF DERMATOLOGY, 1987, 123 (12) :1622-1632
[8]   ULTRAVIOLET-RADIATION INCREASES HIV-LONG TERMINAL REPEAT-DIRECTED EXPRESSION IN TRANSGENIC MICE [J].
FRUCHT, DM ;
LAMPERTH, L ;
VICENZI, E ;
BELCHER, JH ;
MARTIN, MA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (09) :729-733
[9]   PREVALENCE OF CUTANEOUS DISEASE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) OR AIDS-RELATED COMPLEX [J].
GOODMAN, DS ;
TEPLITZ, ED ;
WISHNER, A ;
KLEIN, RS ;
BURK, PG ;
HERSHENBAUM, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (02) :210-220
[10]   DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS-DNA AND RNA IN THE SKIN OF HIV-INFECTED PATIENTS USING THE POLYMERASE CHAIN-REACTION [J].
KANITAKIS, J ;
ESCAICH, S ;
TREPO, C ;
THIVOLET, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (01) :91-96